Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Outline of critical factors to assess before buying crypto, focusing on fundamentals, market context, and prudent decision-making.
26,392 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Two heavyweight names in cloud security are navigating a shifting enterprise landscape. This analysis dives into the ...
Emcor Group combines breadth in facilities management and electrical/mechanical contracting with a steady financial p...
A risk disclosure in SpaceX’s pre-IPO paperwork flags space-based warfare threats to Starlink. As investors watch an ...
Investors often ask if conagra stock long-term buy? This guide breaks down the business, the risks, and what it takes...
Three social platforms are drawing fresh attention as growth meets reasonable prices. Here’s a practical, investor-fr...
A high-flying AI infrastructure stock surged 176% in a single year. This guide breaks down what powered that move, wh...
NVIDIA just raised dividend marks a bold shift in capital allocation as AI demand surges. This guide breaks down what...
A flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
A dramatic security breach at a celebrity home isn’t just news. It offers practical financial lessons on protecting y...
The space economy is heating up, and a few standout names could reshape portfolios. This article breaks down the best...
Artificial intelligence is driving a copper demand surge that outpaces supply. This article breaks down why this meta...